QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
Alfuzosin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.05 – 50 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Alkaline Phosphatase (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 4.17 – 41.7 mU/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | Colorimetric |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Alogliptin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.75 – 200 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anti-diabetic |
| Classification: | Drug Assays |
Alosetron (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.01 – 10 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Diarrhea |
| Classification: | Drug Assays |
Alprazolam (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 50 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anti-Anxiety |
| Classification: | Drug Assays |
Alprazolamα-Hydroxy Alprazolam (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.0500 – 25.0 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Anti-Anxiety |
| Classification: | Drug Assays |
Aluminium (Matrix: Formulation)
| Matrix: | Formulation |
| Assay Range: | 1.00 – 100 µg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | R.T. |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Indigestion |
| Classification: | Drug Assays |
Aluminium (Matrix: Rat Faeces)
| Matrix: | Rat Faeces |
| Assay Range: | 49.9 – 2,017 ng/mg |
| Sample Volume: | 0.25 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Indigestion |
| Classification: | Drug Assays |
Aluminium (Matrix: Rat Urine)
| Matrix: | Rat Urine |
| Assay Range: | 10.0 – 10,000 ng/mL |
| Sample Volume: | 0.25 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Indigestion |
| Classification: | Drug Assays |
Aluminium Zinc (total) (Matrix: Formulation)
| Matrix: | Formulation |
| Assay Range: | 40.0 – 5,120 ng/mL for Aluminium (+ KCl)1.00 – 128 ng/mL for Aluminium (- KCl)40.0 – 2,560 ng/mL for Zinc (+ KCl)1.00 – 128 ng/mL for Zinc (- KCl) |
| Sample Volume: | 2 mL (non acid)0.02 mL (acid) |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | 2 – 8 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Indigestion |
| Classification: | Drug Assays |
Ambroxol (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 200 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Respiratory |
| Classification: | Drug Assays |
Amisulpride (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 – 3,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Antiemetic and Antipsychotic |
| Classification: | Drug Assays |
Amlodipine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 25 – 5,000 pg/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Amlodipine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.05 – 5 ng/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Amlodipine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.05 – 10 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Amlodipine Telmisartan (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 14 ng/mL 3 – 1500 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Amoxicillin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 200 – 20,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Amphetamine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Stimulant |
| Classification: | Drug Assays |
Amphetamine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 to 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | K2 EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Stimulant |
| Classification: | Drug Assays |
Amprenavir (APV) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 100 – 10,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Amprenavir (APV)
Indinavir (IDV)
Nelfinavir (NFV)
Saquinavir (SQV) (Matrix: Human Plasma)
Indinavir (IDV)
Nelfinavir (NFV)
Saquinavir (SQV) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 1,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Anastrozole (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 20 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Anastrozole (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 25 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Apixaban (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1.3 – 400 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Apolipoprotein E (ApoE) (112T>C, 158C>T) Genotyping (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | N/A |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | Pyrosequencing |
| Site: | QPS-Delaware |
| CLIA: | Yes |
| Therapy Area: | Alzheimer’s Disease |
| Classification: | Genomic Biomarkers |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
